{
  "id": "PD_BRADYCARDIA_ADDITIVE",
  "name": "Additive bradycardia risk with multiple HR-lowering drugs",
  "domain": "PD",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "actions": [
    "Avoid combining multiple HR-lowering drugs when feasible (educational).",
    "Monitor heart rate, blood pressure, dizziness, syncope symptoms.",
    "Use extra caution with conduction disease or baseline bradycardia."
  ],
  "logic": {
    "pd_overlap": {
      "effect_id": "bradycardia",
      "min_magnitude": "medium"
    },
    "rationale": [
      "Both drugs lower heart rate.",
      "Combined effects can increase symptomatic bradycardia risk."
    ]
  },
  "explanation_template": "{A_name} and {B_name} both have HR-lowering (bradycardia) effects. Using them together can increase bradycardia-related risk.",
  "references": [
    {
      "source": "Educational note",
      "citation": "PD stacking: additive HR-lowering effects can increase symptomatic bradycardia risk."
    }
  ]
}
